Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2019

Every FDA drug recall initiated in 2019, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,788 recalls, newest first.

Class II · Moderate risk

Robafen DM

CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Preferred Pharmaceuticals, Inc NDC 68788-0841-01 D-1410-2019
Class I · High risk

Hydromorphone HCl in 0.9% sodium chloride

Incorrect Product Formulation; Firm's customer resource center (CRC) statement indicates that the product is sulfite free, however the product is produced with a raw material that contains sulfite

Terminated Other PharMEDium Services, LLC NDC 61553-352-78 D-1488-2019
Class II · Moderate risk

Cetirizine Oral Solution 1 mg/mL

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination P & L Developments, LLC NDC 11673-178-04 D-1409-2019
Class II · Moderate risk

Cetirizine Oral Solution 1 mg/mL

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination P & L Developments, LLC NDC 63868-430-04 D-1408-2019
Class II · Moderate risk

Cetirizine HCL Oral Solution 1 mg/mL

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination P & L Developments, LLC NDC 55910-878-04 D-1407-2019
Class II · Moderate risk

Allergy Relief D

Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Terminated Impurity / degradation Sun Pharmaceutical Industries, Inc. D-1388-2019
Class II · Moderate risk

Allergy Relief D

Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Terminated Impurity / degradation Sun Pharmaceutical Industries, Inc. D-1387-2019
Class II · Moderate risk

Estradiol Vaginal Inserts USP 10 mcg

Defective Delivery System: Estradiol Vaginal Inserts USP plunger is not functioning properly.

Terminated Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-711-71 D-1340-2019

Recalls by year